Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Supriya Lifescience Ltd.	Q V+ PT	7,288 Small Cap	949.30 (-0.90%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Anthem Biosciences Ltd.	Q V PT	52,619 Mid Cap	907.55 (-1.18%)	89.86	16.54	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Fortis Healthcare Ltd.	Q V+ PT	66,059 Mid Cap	904 (0.78%)	64.62	6.66	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Aarti Pharmalabs Ltd.	Q V+ PT	7,443 Small Cap	893 (5.50%)	36.88	3.74	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Granules India Ltd.	Q V+ PT	23,868 Small Cap	861.35 (-1.61%)	59.27	5.81	2.07	-5.88	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Alembic Pharmaceuticals Ltd.	Q V+ PT	16,623 Small Cap	843.80 (-0.77%)	24.1	2.86	6.37	-8.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Akums Drugs & Pharmaceuticals Ltd.	Q V+ PT	12,339 Small Cap	817.35 (-0.47%)	44.31	3.78	9.87	8.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Natco Pharma Ltd.	Q V+ PT	14,578 Small Cap	815.70 (-0.10%)	12.78	1.57	14.72	28.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Krishna Institute of Medical Sciences Ltd	Q V PT	34,063 Small Cap	795 (0.70%)	162.31	8.76	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Nephrocare Health Services Ltd.	Q V+ PT	7,478 Small Cap	753.60 (0.28%)	98.35	6.66	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Solara Active Pharma Sciences Ltd.	Q V PT	3,574 Small Cap	752.05 (-0.60%)	N/A	2.87	-3.27	-145.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Aster DM Quality Care Ltd.	Q V+ PT	65,885 Mid Cap	751.10 (-0.71%)	206.91	15.59	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Healthcare Global Enterprises Ltd.	Q V+ PT	10,580 Small Cap	710.15 (1.35%)	626.07	6.5	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Bliss GVS Pharma Ltd.	Q V+ PT	7,235 Small Cap	687.75 (4.59%)	51.34	5.67	9.94	8.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Vimta Labs Ltd.	Q V+ PT	2,695 Small Cap	610.45 (-0.95%)	34.58	5.85	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Lincoln Pharmaceuticals Ltd.	Q V PT	1,215 Small Cap	602.55 (-0.53%)	12.58	1.53	10.03	10.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Metropolis Healthcare Ltd.	Q V PT	12,396 Small Cap	595.75 (0.18%)	61.19	7.91	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Indegene Ltd.	Q V+ PT	14,398 Small Cap	592.55 (-0.60%)	35.83	4.48	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Thyrocare Technologies Ltd.	Q V+ PT	8,848 Small Cap	589.15 (3.08%)	51.6	14.45	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Blue Jet Healthcare Ltd.	Q V PT	10,887 Small Cap	583.95 (0.75%)	46.7	4.9	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Krsnaa Diagnostics Ltd.	Q V PT	1,757 Small Cap	570.25 (2.71%)	18.48	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Unichem Laboratories Ltd.	Q V PT	3,841 Small Cap	550.70 (2.06%)	12.46	1.38	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	One Global Service Provider Ltd.	Q V+ PT	1,056 Small Cap	530.05 (-1.38%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Sai Parenterals Ltd.	Q V PT	2,257 Small Cap	507.10 (-0.78%)	136.82	2.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Amrutanjan Health Care Ltd.	Q V+ PT	1,427 Small Cap	501 (1.12%)	26.54	3.82	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Dr. Agarwals Health Care Ltd.	Q V PT	15,845 Small Cap	492.05 (0.46%)	104.66	7.51	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	SMS Pharmaceuticals Ltd.	Q V+ PT	4,148 Small Cap	485.45 (4.07%)	42.66	5.42	9.51	7.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Fermenta Biotech Ltd.	Q V PT	1,400 Small Cap	473.70 (-0.13%)	23.08	3.38	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Cohance Lifesciences Ltd.	Q V+ PT	16,760 Small Cap	457.10 (-0.76%)	165.89	4.58	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Gufic Biosciences Ltd.	Q V PT	4,368 Small Cap	443 (1.68%)	59.48	6.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

One Global Service Provider informs about corrigendum to AGM notice

In continuation of its intimation dated 5th September, 2026 regarding the Notice convening the 34th Annual General Meeting (‘AGM’) of the Company dated 3rd September, 2026 (‘AGM Notice’), scheduled to be held on Tuesday, 29th September, 2026 at 02:00 PM IST, One Global Service Provider has informed that a Corrigendum to the AGM Notice (‘Corrigendum’) is being sent today, Monday, 21st September, 2026, through email to the Members to whom the AGM Notice has been dispatched. The Corrigendum provides certain clarifications, modifications, and updates to the resolution and explanatory statement of Item No. 10 of the AGM Notice. A copy of the detailed Corrigendum is enclosed. The Corrigendum to the AGM Notice shall form an integral part of the AGM Notice, the AGM Notice shall always be read in conjunction with this Corrigendum. All other contents of the AGM Notice, save and except as modified or supplemented by Corrigendum, shall remain unchanged. The Corrigendum is also available on the website of the Company at www.1gsp.in and on the website of National Securities Depository Services at www.evoting.nsdl.com. The e-voting period commences on Friday, 25th September, 2026 (09.00 AM IST) and ends on Monday, 28th September, 2026 (05.00 PM IST).

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

The inspection concluded with the issuance of a Form FDA 483 containing five observations

Sep, 2026

HealthCare Global Enterprises informs about AGM

HealthCare Global Enterprises has informed that 28th Annual General Meeting (AGM) of the Members of the Company was held on Friday, September 18, 2026, at 5.00 pm (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAV) in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and circulars issued by the Securities and Exchange Board of India (SEBI) and as per the applicable provisions of the Companies Act, 2013 and Listing Regulations. All the resolutions set out in the AGM notice have been approved by the Members with requisite majority. In this regard, they are enclosing the following: Consolidated report dated September 18, 2026, of the Scrutinizer signed by Mr. Pradeep B Kulkarni, Partner, V. Sreedharan & Associates, Company Secretaries, on e-voting and voting at the Annual General Meeting, in compliance with the provisions of Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules 2014, annexed as Annexure-A and Voting results in compliance with Regulation 44(3) of the Listing Regulations read with SEBI Circular, annexed as Annexure- B.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Unichem Laboratories informs about disclosure

Unichem Laboratories has informed that with reference to earlier intimation dated 24th January 2025, the Company has received Order-In-Appeal from Commissioner (Appeals Thane). Relevant details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are provided in Annexure A. The Company shall take all appropriate remedial steps including filing of an appeal within prescribed timelines.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	57,954 Crore
2	Neuland Laboratories Ltd.	29,349 Crore
3	Divis Laboratories Ltd.	2,48,664 Crore
4	Apollo Hospitals Enterprise Ltd.	1,26,103 Crore
5	Astrazeneca Pharma India Ltd.	16,879 Crore
6	Kovai Medical Center & Hospital Ltd.	6,820 Crore
7	Procter & Gamble Health Ltd.	9,133 Crore
8	Alkem Laboratories Ltd.	65,780 Crore
9	Dr Agarwals Eye Hospital Ltd.	2,598 Crore
10	Torrent Pharmaceuticals Ltd.	1,82,738 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

One Global Service Provider informs about corrigendum to AGM notice

Cohance Lifesciences informs about update

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

HealthCare Global Enterprises informs about AGM

Krsnaa Diagnostics informs about updates

Unichem Laboratories informs about disclosure

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?